AKT1 and glioblastoma: shRNA-mediated knockdown of INPP5K in PTEN-deficient U-87MG glioblastoma cells had no effect on tumour survival or proliferation, indicating that INPP5K depletion does not further enhance the amplified PI3K/AKT signals that occur as a consequence of PTEN loss [147].